Clinical Trial for Safety of H1N1 Vaccine Monitored for 13 Months

Jeffry John Aufderheide
September 3, 2009

( At the eleventh hour, more details of the Swine Flu vaccine are being revealed. Immunoe, a Denver based research center, is participating in the Novartis clinical research trial evaluating the use of the experimental H1N1 vaccine in children. Immunologist Isaac Melamed, M.D. is the lead research scientist on this project. According to the document posted on Immunoe’s website, safety monitoring for the experimental H1N1 vaccine will be conducted for 13 months which extends far beyond the flu season.

IMMUNOe's H1N1 Flier (pg 3)

IMMUNOe's H1N1 Flier (pg 3)

This information is critical, as Paul Joseph Watson of, broke a story yesterday, “CDC Warns Neurologists To Watch For Nerve Disease Following Swine Flu Shots,” detailing the CDC’s concern over neurological complications due to the H1N1 vaccine.

Interestingly, this so-called “safety trial” is being conducted by an immunologist and not a neurologist. Phone conversations with the research coordinators confirmed that no neurological measures will be conducted before or after vaccination. Followup ‘safety checks’ will be done over the phone once a month for the next thirteen months.

Shortly following the aforementioned question on ‘How long will the clinical research trial take?’, is an equally intriguing question, “Is the new H1N1 vaccine safe?” Imagine my surprise when I read this.  Immunoe’s reply?

‘The investigational H1N1 vaccine that is being tested in this clinical research trial is similar to a seasonal influenza vaccine, which is licensed for use in the U.S. The licensed vaccine is generally well tolerated, and the most common side effect of vaccination is soreness at the injection site. Less common side effects include fever, malaise, muscle pain, allergic reactions, egg hypersensitivity and anaphylaxis.”

It is apparent that Immunoe skillfully dodged the question due to self preservation. How can they say the vaccine is safe if they are monitoring the side effects for 13 months? Is Novartis truly interested in the well-being of our children or is this just another attempt to slam home an ad hoc solution with disastrous consequences for future generations? This should also bring into question if this ‘relatively-regarded-as-safe-vaccine” is monitored for thirteen months, why are not vaccines on the normal vaccine schedule followed up with such tenacity?
About the author

Jeffry John Aufderheide

Jeffry John Aufderheide is the father of a child injured as a result of vaccination. As editor of, he promotes well-educated health professionals, informed consent, and full disclosure and accountability of adverse reactions to vaccines.

Comments are closed